Related Articles
Clinicopathological characteristics, adjuvant chemotherapy decision and disease outcome in patients with breast cancer with a 21‑gene recurrence score of 26‑30
Clinical analysis of 21-gene relapse score test in hormone receptor-positive early-stage breast cancer Corrigendum in /10.3892/ol.2021.12572
Molecular subtype can predict the response and outcome of Chinese locally advanced breast cancer patients treated with preoperative therapy
O6‑methylguanine‑DNA methyltransferase as a prognostic and predictive marker for basal‑like breast cancer treated with cyclophosphamide‑based chemotherapy
Association between body mass index and breast cancer intrinsic subtypes in Japanese women